ODDB.org: Open Drug Database

Swissmedic Registration	68023	Date of registration	17.02.2022
Company name	GlaxoSmithKline AG	Revision date
		Valid until	21.12.2028
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Jemperli 500 mg/10 ml	Konzentrat zur Herstellung einer Infusionslösung	Concentrate for infusion (Dostarlimabum 500mg / 10ml)	L01FF07

2025	©ywesee GmbH